Why do promising CNS therapies struggle to translate into patients? Three experts explore how biomarkers can track ...
Researchers at the University of Basel have screened more than 1,600 compounds using a biobank of 35 hepatocellular carcinoma ...
Humanised antibodies targeting the voltage-gated sodium channel Nav1.7 have demonstrated prolonged suppression of neuropathic ...
A bacterial enzyme produced by Bacteroides vulgatus has been shown to inactivate the intestinal hormone GLP-2, disrupting gut ...
Researchers at the Salk Institute have identified a cellular pathway through which prolonged interferon exposure triggers ...
Whole-genome sequencing of parasites from Ugandan patients has uncovered a cluster of genetic variants linked to reduced ...
A comprehensive review of solute carrier transporters argues that the 464-strong SLC protein family represents a largely ...
A nasal spray using extracellular vesicles derived from the amniotic membrane has shown promise against Alzheimer's disease, ...
Scientists at the Salk Institute have constructed a comprehensive atlas of previously uncharacterised microproteins in the human frontal cortex, identifying over 1,000 novel candidates.
An experimental synthetic non-coding RNA drug has reversed signs of systemic sclerosis in patient-derived immune cells and ...
As spatial proteomics advances, how can researchers find the complex biology of the prostate tumour microenvironment while ...
A £20 million high-security facility in Liverpool is set to accelerate drug and vaccine discovery by integrating artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results